There is however a rising tide of competition in atopic dermatitis, including another IL-13-targeting antibody from Eli Lilly’s recently acquired Dermira – lebrikizumab – which recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback